Canadian College of Naturopathic Medicine (CCNM)
The Canadian College of Naturopathic Medicine (CCNM) has established itself as a North American leader for research in naturopathic
medicine. Described below are some of the areas in which this leadership is being exhibited. The research publications referenced are all listed at http://www.ccnm.edu/research/research-abstracts with links to the abstracts describing the study.
This has become one of the primary areas of research at CCNM, and much of the research is being conducted at the Ottawa Integrative Cancer Centre (OICC), an arm of CCNM. At the OICC, we are committed to studying the safety and effectiveness of complementary treatments used by people living with cancer. The OICC has ongoing research underway supported by grants of over $8 million Canadian. Ongoing research includes:
- The Canadian/US Integrative Oncology Study (CUSIOS). Advanced integrative oncology treatment for patients with advanced stage cancer. Working in partnership with Bastyr University, the OICC/CCNM research teams have initiated a North American study to explore the impact of integrative care delivered by NDs for patients with advanced cancer. This study will run over six years with the goal of enrolling over 400 patients with late stage cancer. Outcomes associated with quality of life and survival will be assessed.
- The Thoracic Peri-Operative Integrative Surgical Care Evaluation (POISE) Trial: (The Thoracic POISE Trial). Working in collaboration with the Ottawa Hospital Research Institute (OHRI), the OICC has launched an 11 year study to explore the impact of integrative cancer care for patients with lung and gastroesophageal cancers. This study uses a pragmatic randomized design to enroll patients into either a combination of conventional and complementary medicine care (integrative care group) or conventional care alone (control group). Outcomes associated with thoracic surgery, quality of life, survival and cost effectiveness will be evaluated.
- Adjuvant Melatonin in the Prevention of Recurrence and Mortality Following Lung Cancer Resection: A Randomized Placebo Controlled Clinical Trial (AMPLCaRe). Conducted in conjunction with the Ottawa Hospital, this is a double-blind randomized trial study that has enrolled 730 participants in eight hospital sites across Canada. This trial is examining the effect of melatonin on the reduction of recurrence and mortality for individuals with non-small cell lung cancer. Underway since 2008, results will soon be available once final outcomes are all collected and participant allocations un-blinded.
- A patient-centred decision aid for women with a history of breast cancer who are considering natural therapies to help control their hot flashes.
CCNM is conducting a randomized controlled trial to assess the effectiveness of adjunctive naturopathic care for individuals with type 2 diabetes. The information collected will assess inter-professional collaboration, blood sugar control, patient adherence, and long-term risk reduction as a result of integrative care. This study is being undertaken in conjunction with Brampton Civic Hospital and a Brampton family health team.
Research on the Efficacy of Naturopathic Therapies for Workplace Ailments
CCNM conducted four studies in conjunction with Canada Post Corporation and the Canadian Union of Postal Workers to determine if naturopathic treatments could assist in reducing or resolving health issues that were impacting the employees’ ability to perform their jobs. Four studies were conducted and all four have been published in peer reviewed journals. The studies examined rotator cuff tendonitis, anxiety, chronic back pain and the reduction of cardiovascular risk. The cardiovascular study was a multi-centred study and the results were published in the Canadian Medical Association Journal http://www.cmaj.ca/content/early/2013/04/29/cmaj.120567 .
Two of the Canada Post studies had companion studies published examining the economic impact of the addition of naturopathic care. In addition, the diabetes study currently underway has been designed to include an economic assessment as well. The Thoracic POISE trial will also incorporate an evaluation of cost effectiveness by measuring post-surgical hospital length of stay, among other direct and indirect expenses, through the duration of the trial.
Other areas of publications and/or current studies include inter alia herb/drug interactions, mental health, orthomolecular medicine, pediatrics, pregnancy and lactation, digestive health, and research methodology.